1. Beal SL, Sheiner LB (1979, 1989) NONMEM (user's guide), parts I?VI. Technical report. Division of Clinical Pharmacology, University of California, San Francisco
2. Camaggi CM, Strocchi E, Tamassia V, Martoni A, Giovannini M, Iafelice G, Canova N, Marraro D, Martini A, Pannuti F (1982) Pharmacokinetic studies of 4?-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. Cancer Treat Rep 66:1819?1824
3. Cersosimo RJ, Hong WK (1986) Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an Adriamycin analogue. J Clin Oncol 4:425?439
4. Eksborg S (1989) Pharmacokinetics of anthracyclines. Acta Oncol 28:873?876
5. Evans WE, Relling MV (1989) Clinical pharmacokinetics-pharmacodynamics of anticancer drugs. Clin Pharmacokinet 16: 327?336